Emerging Tick-Borne Illnesses: Not Just Lyme Disease Part 1

Tick Borne Illness

Tick-borne disease surveillance studies have shown increasing prevalence, transmission, and disease burden over the last decade. Tick-borne illnesses remain a public health threat and the true incidence remains unknown and is thought to be underrepresented. Although Lyme Disease is the most frequently reported tick-borne disease in the United States, the incidence of four other tick-borne diseases is noted to be increasing in the United States:

  1. Anaplasmosis (Nov 3rd, 2020)
  2. Ehrlichiosis (Nov 4th, 2020)
  3. Rocky Mountain Spotted Fever (Nov 5th, 2020)
  4. Babesiosis (Nov 6th, 2020)

In this five-part post, we will review the salient features of these other emerging tick-borne illnesses to increase recognition of these disease entities.

This overview will serve to lay a foundation and summarize shared features of tick-borne illnesses prior to diving into each specific disease.

History and Physical:

A thorough history should inquire about the following in order to help make a presumptive diagnosis:

  • Recent Tick Exposure
  • Recreational or Occupational History/Exposure
  • Travel History
  • Occurrences of Similar Symptoms in Family Members, Coworkers, and Animals (dogs)
  • Absence of a recognized tick bite does not rule out the consideration of tick-borne illness in the right clinical context

Poor Prognostic Factors:

  • Increased Age
  • Immunocompromised States
  • Delays in Diagnosis and Treatment

Signs/Symptoms and Laboratory Work-Up:

Tick-borne diseases have several shared signs, symptoms, and laboratory findings.

  • A simplified way to approach tick-borne illnesses is to look for the presence of unexplained fever along with non-specific flu-like symptoms
  • These clinical symptoms along with thrombocytopenia and transaminitis should clue the clinician into further exploring tick-bore illnesses as an etiology of the patient’s symptoms

 

Management of Tick-Borne Illnesses

Anaplasmosis-Ehrlichiosis-Rocky Mountain Spotted Fever:

Doxycycline is the drug of choice in both pediatric and adult patients (Biggs 2016)

  • 100 mg orally or intravenously twice daily for 10 days
  • 2 mg/kg (not to exceed 100 mg/dose) twice daily for 10 days in children
  • Response to therapy is rapid and failure to improve within 48 hours of treatment suggests possibility of alternative diagnosis.
  • The American Academy of Pediatrics and the CDC recommend doxycycline in the pediatric population as the risks of dental staining stem from older tetracycline-class drugs that bound more readily to calcium than newer agents such as doxycycline (Biggs 2016).
  • Studies have shown a tooth discoloration rate of 0% in children less than 8 years of age treated with doxycycline (Biggs 2016, Todd 2015, Volovitz 2007).

Rifampin: Possible alternative agent for Anaplasmosis or Ehrlichiosis in those with severe doxycycline allergy or mild infection in the pregnant patient.

  • 300 mg orally twice daily for adults for 10 days
  • 10 mg/kg (not to exceed 300mg/dose) twice daily for 10 days in children

Chloramphenicol: Possible alternative agent for Rocky Mountain Spotted Fever

  • 50-75 mg/kg intravenously every 6 hours for 7-19 days

Babesiosis:

Doxycycline does not cover Babesia species

Mild to Moderate Disease: Atorvaquone plus Azithromycin

  • Atorvaquone: 750 mg orally twice daily for 7-10 days
  • Azithromycin: 500 mg orally on day 1 followed by 250 mg orally once daily for 7-10 days

Severe Disease: Clindamycin plus Quinine

  • Clindamycin: 300-600 mg intravenously every 6 hours for 7-10 days
  • Quinine: 650 mg orally every 6 hours for 7-10 days

Exchange Transfusion

  • Indications: Parasitemia > 10%, Severe Anemia, Pulmonary, Liver, or Renal Impairment

Take Home Approach:

Guest Post By:

Akash Ray, DO
PGY-2 Emergency Medicine Resident Inspira Medical Center
Vineland, NJ
Twitter: @_kashray

References:

  1. Biggs H et al. Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis – United States. MMWR Recomm Rep. 2016. PMID: 27172113
  2. Todd S et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. J Pediatr. 2015. PMID: 25794784
  3. Volovitz B et al. Absence of tooth staining with doxycycline treatment in young children. Clin Pediatr (Phila). 2007. PMID: 17325084

Post Peer Reviewed By: Salim R. Rezaie, MD (Twitter: @srrezaie)

Cite this article as: Muhammad Durrani, "Emerging Tick-Borne Illnesses: Not Just Lyme Disease Part 1", REBEL EM blog, November 2, 2020. Available at: https://rebelem.com/emerging-tick-borne-illnesses-not-just-lyme-disease-part-1/.
The following two tabs change content below.

Muhammad Durrani

Assistant Clerkship Director & Assistant Research Director at Inspira Medical Center

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on email
Share via Email

Want to support rebelem?

Leave a Comment

Time limit is exhausted. Please reload CAPTCHA.

Sponsored

0